Company profile for Affinivax

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Affinivax is a clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology – called Multiple Antigen Presenting System (MAPS) – enables the high affinity binding of protective polysaccharides as well as proteins in a single vaccine, uniquely induci...
Affinivax is a clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology – called Multiple Antigen Presenting System (MAPS) – enables the high affinity binding of protective polysaccharides as well as proteins in a single vaccine, uniquely inducing a broad and protective B- and T-cell immune response.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Cambridge, Massachusetts US
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/pwtoday-story/gsk-completes-acquisition-of-affinivax-inc

PHARMIWEB
16 Aug 2022

https://www.businesswire.com/news/home/20220621005366/en

BUSINESSWIRE
21 Jun 2022

https://www.reuters.com/markets/deals/britains-gsk-buy-affinivax-33-bln-deal-2022-05-31/

REUTERS
31 May 2022

https://www.businesswire.com/news/home/20220502005210/en

BUSINESSWIRE
02 May 2022

https://www.businesswire.com/news/home/20220228006050/en

BUSINESSWIRE
01 Mar 2022
Affinivax Appoints Rick Malley as CSO
Affinivax Appoints Rick Malley as CSO

22 Dec 2021

// BUSINESSWIRE

https://www.businesswire.com/news/home/20211222005162/en/Affinivax-Appoints-Rick-Malley-MD-as-Chief-Scientific-Officer

BUSINESSWIRE
22 Dec 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty